Recently, it was elucidated that in male HCC and hepatoma cell lines, the NEAT1v1-superoxide dismutase 2 (SOD2) axis confers lenvatinib and sorafenib resistance and shifts the growth mode from MEK/ERK-dependent to Akt-dependent mode [265]. Here, AKT1 is linked to hepatocellular carcinoma.